menu
    • menu

    Company profile for Venus Medtech

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company’s self-developed product, VenusA-Valve, is the first transcatheter aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China. As the pioneer in the transcatheter heart valve industry in C...
    Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company’s self-developed product, VenusA-Valve, is the first transcatheter aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China. As the pioneer in the transcatheter heart valve industry in China, the Company enjoys first mover advantages. The Company’s mission is to become a global leader in the development and commercialization of transcatheter solutions for structural heart diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Venus MedtechChina Flag
    Country
    Country
    China
    Address
    Address
    Room 311, 3/F, Block 2, No. 88, Jiangling Road, Binjiang District, Hangzhou
    Telephone
    Telephone
    +86 0571 8675 9022
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.venusmedtech.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiovalve Finishes TARGET Study Enrollment For Tricuspid Valve
    Cardiovalve Finishes TARGET Study Enrollment For Tricuspid Valve

    25 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cardiovalve-completes-target-study-enrollment-for-ce-registration-study-for-tricuspid-valve-replacement-302593458.html

    PR NEWSWIRE
    25 Oct 2025
    Share Share
    Venus Medtech to showcase its structural heart treatments at London Valves 2022
    Venus Medtech to showcase its structural heart treatments at London Valves 2022

    25 Nov 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/venus-medtech-to-showcase-its-structural-heart-treatments-at-london-valves-2022-301687170.html

    PRNEWSWIRE
    25 Nov 2022
    Share Share
    Venus Medtech Acquires Cardiovalve to Optimize Innovative Products Pipeline
    Venus Medtech Acquires Cardiovalve to Optimize Innovative Products Pipeline

    07 Dec 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/venus-medtech-acquires-cardiovalve-to-optimize-its-innovative-products-pipeline-of-mitral-and-tricuspid-valve-replacement/?s=79

    BIOSPACE
    07 Dec 2021
    Share Share
    Venus Concept to Release Q2 of Fiscal Year 2021 Financial Results
    Venus Concept to Release Q2 of Fiscal Year 2021 Financial Results

    08 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/08/2260224/0/en/Venus-Concept-to-Release-Second-Quarter-of-Fiscal-Year-2021-Financial-Results-on-August-13-2021.html

    GLOBENEWSWIRE
    08 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search